221 related articles for article (PubMed ID: 23823982)
21. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
[TBL] [Abstract][Full Text] [Related]
22. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
Amyes E; Curnow J; Stark Z; Corlett L; Sutton I; Vincent A
J Neuroimmunol; 2001 Mar; 114(1-2):259-64. PubMed ID: 11240040
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Tokiguchi S; Shinozawa K; Tsuji S
J Neurol Sci; 1999 Sep; 168(1):28-31. PubMed ID: 10500270
[TBL] [Abstract][Full Text] [Related]
24. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
26. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
27. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
[TBL] [Abstract][Full Text] [Related]
28. Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
Peter E; Treilleux I; Wucher V; Jougla E; Vogrig A; Pissaloux D; Paindavoine S; Berthet J; Picard G; Rogemond V; Villard M; Vincent C; Tonon L; Viari A; Honnorat J; Dubois B; Desestret V
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35821104
[TBL] [Abstract][Full Text] [Related]
29. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
Le May M; Dent S
Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
[TBL] [Abstract][Full Text] [Related]
30. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
32. Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy.
Bartley CM; Parikshak NN; Ngo TT; Alexander JA; Zorn KC; Alvarenga BA; Kang MK; Pedriali M; Pleasure SJ; Wilson MR
Front Neurol; 2021; 12():728700. PubMed ID: 34744969
[TBL] [Abstract][Full Text] [Related]
33. Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration.
Carpenter EL; Vance BA; Klein RS; Voloschin A; Dalmau J; Vonderheide RH
J Neuroimmunol; 2008 Jan; 193(1-2):173-82. PubMed ID: 18053582
[TBL] [Abstract][Full Text] [Related]
34. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival.
Okano HJ; Park WY; Corradi JP; Darnell RB
Genes Dev; 1999 Aug; 13(16):2087-97. PubMed ID: 10465786
[TBL] [Abstract][Full Text] [Related]
35. Proteasome antibodies in paraneoplastic cerebellar degeneration.
Storstein A; Knudsen A; Vedeler CA
J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.
Smith JL; Finley JC; Lennon VA
J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
Bradwell AR
Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
[No Abstract] [Full Text] [Related]
38. CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration.
Greenlee JE; Carlson NG
Ann Neurol; 2020 Aug; 88(2):428. PubMed ID: 32445212
[No Abstract] [Full Text] [Related]
39. Reply to "CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration".
Kråkenes T; Herdlevaer I; Raspotnig M; Haugen M; Schubert M; Vedeler C
Ann Neurol; 2020 Aug; 88(2):429. PubMed ID: 32445220
[No Abstract] [Full Text] [Related]
40. Multi-omics profiling reveals dysregulated ribosome biogenesis and impaired cell proliferation following knockout of CDR2L.
Solheim ET; Gerking Y; Kråkenes T; Herdlevær I; Birkeland E; Totland C; Dick F; Vedeler CA
BMC Cancer; 2024 May; 24(1):645. PubMed ID: 38802745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]